These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6676485)

  • 1. [Serum lipids and lipoproteins during therapy in a patient with familial type III hyperlipoproteinemia].
    Tozuka M; Hidaka H; Kanai M; Horigome R; Takase Y
    Rinsho Byori; 1983 Dec; 31(12):1317-24. PubMed ID: 6676485
    [No Abstract]   [Full Text] [Related]  

  • 2. [Type III hyperlipoproteinemia in idiopathic hemochromatosis].
    Feussner G; Ziegler R
    Klin Wochenschr; 1990; 68 Suppl 22():100-1. PubMed ID: 2087060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas-liquid chromatography profiling of intact lipids. Observation of differences between triglyceride structure of lipoproteins in type III and type IV hyperlipoproteinemia.
    Skorepa J; Kahudová V; Kotrlíková E; Mares P; Todorovicová H
    J Chromatogr; 1983 Mar; 273(1):180-6. PubMed ID: 6853647
    [No Abstract]   [Full Text] [Related]  

  • 4. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced hyperlipidemia in a patient with pre-existing dysbetalipoproteinemia.
    Henann NE
    Clin Pharm; 1986 Sep; 5(9):761-4. PubMed ID: 3757448
    [No Abstract]   [Full Text] [Related]  

  • 6. [Type III hyperlipoproteinemia. A review and clinical and biochemical findings in 11 patients].
    Faergeman O; Meinertz H
    Ugeskr Laeger; 1980 Mar; 142(13):816-9. PubMed ID: 7368367
    [No Abstract]   [Full Text] [Related]  

  • 7. Type III hyperlipoproteinaemia: the turnover rate of plasma triglycerides and the response to clofibrate.
    Stuyt PM; Demacker PN; Stalenhoef AF; Schade RW; Lutterman JA; van't Laar A
    Neth J Med; 1982; 25(8):245-54. PubMed ID: 7144991
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial hyperlipoproteinemia showing an interconversion between type III and V linked with a trait of xeroderma pigmentosum.
    Yamamura T; Sudo H; Matsuzawa Y; Yamamoto A
    Med J Osaka Univ; 1979 Sep; 30(1-2):5-14. PubMed ID: 232901
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Normalization of lipid levels in an 87-year-old woman with a type III dysbetalipoproteinemia by ethinyl estradiol (author's transl)].
    De Gennes JL; Dairou F; Epelboin S; Tuffert J
    Ann Med Interne (Paris); 1980; 131(7):410-5. PubMed ID: 7224448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pancreatitis in type III hyperlipoproteinemia].
    Feussner G
    Internist (Berl); 1987 Jun; 28(6):393-5. PubMed ID: 3301725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endocytosis of lipoproteins by the liver and their intracellular transport in comparison with other ligands].
    Windler E; Jäckle S; Greten H
    Z Gastroenterol Verh; 1990 Apr; 25():39-41. PubMed ID: 1694361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inborn errors of metabolism. XXI. Familial hyperlipoproteinemia type II--serum lipids in 113 patients].
    Sobra J; Heybrovský A; Horáková D
    Cas Lek Cesk; 1970 Sep; 109(42):988-90. PubMed ID: 5473809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of procetofen on lipoproteins and blood lipids in patients with hyperlipemia].
    Abaurre R; Vega J; Maneschi E; Bernabe H
    Medicina (B Aires); 1980; 40(6 Pt 2):896. PubMed ID: 7219169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoproteins].
    Yamamoto A; Yamamura T; Taka-Ich S
    Rinsho Byori; 1983 Aug; 31(8):863-73. PubMed ID: 6655919
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.
    Feussner G; Ziegler R
    Hum Genet; 1991 Jan; 86(3):326-8. PubMed ID: 1997392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.